Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 Objective 1
1.10.2 Objective 2
1.10.3 Objective 3
1.10.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Competitive Insights
Chapter 3 Radiotheranostics Market Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent market
3.2 Market Dynamics
3.2.1 Market drivers analysis
3.2.1.1 Increasing prevalence of cancer
3.2.1.2 Growing use of radiotheranostics in cancer diagnosis and management
3.2.1.3 Rising trend of nuclear medicine
3.2.2 Market restraint analysis
3.2.2.1 Requirement of higher cost for radiotheranostics development
3.2.2.2 Short shelf life of theranostic agents
3.3 Radiotheranostics: Market Analysis Tools
3.3.1 Industry analysis – Porter’s
3.3.2 PESTLE analysis
3.4 Regulatory Framework
Chapter 4 Radiotheranostics Market Segment Analysis, By Radioisotope, 2018 – 2030 (USD Million)
4.1 Definition and Scope
4.2 Radioisotope Market Share Analysis, 2022 & 2030
4.3 Segment Dashboard
4.4 Global Radiotheranostics Market, by Radioisotope, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
4.5.1 Iodine-131
4.5.1.1 Iodine-131 market estimates and forecast, 2018 – 2030 (USD Million)
4.5.2 Iodine-123
4.5.2.1 Iodine-123 market estimates and forecast, 2018 – 2030 (USD Million)
4.5.3 Gallium-68
4.5.3.1 Gallium-68 market estimates and forecast, 2018 – 2030 (USD Million)
4.5.4 Lutetium-177
4.5.4.1 Lutetium-177 market estimates and forecast, 2018 – 2030 (USD Million)
4.5.5 18F with Y-90
4.5.5.1 18F with Y-90 market estimates and forecast, 2018 – 2030 (USD Million)
4.5.6 Others
4.5.6.1 Others market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 5 Radiotheranostics Market Segment Analysis, By Approach 2018 – 2030 (USD Million)
5.1 Definition and Scope
5.2 Approach Market Share Analysis, 2022 & 2030
5.3 Segment Dashboard
5.4 Global Radiotheranostics Market, by Approach, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
5.5.1 Targeted Therapeutic
5.5.1.1 Targeted therapeutic market estimates and forecast, 2018 – 2030 (USD Million)
5.5.2 Targeted Diagnostic
5.5.2.1 Targeted diagnostic market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 6 Radiotheranostics Market Segment Analysis, By Application, 2018 – 2030 (USD Million)
6.1 Definition and Scope
6.2 Application Market Share Analysis, 2022 & 2030
6.3 Segment Dashboard
6.4 Global Radiotheranostics Market, by Application, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
6.5.1 Oncology
6.5.1.1 Oncology market estimates and forecast, 2018 – 2030 (USD Million)
6.5.1.2 Thyroid Cancer
6.5.1.2.1 Thyroid cancer market estimates and forecast, 2018 – 2030 (USD Million)
6.5.1.3 Neuroendocrine Tumors
6.5.1.3.1 Neuroendocrine tumors market estimates and forecast, 2018 – 2030 (USD Million)
6.5.1.4 Hepatocellular Carcinoma
6.5.1.4.1 Hepatocellular carcinoma market estimates and forecast, 2018 – 2030 (USD Million)
6.5.1.5 Prostate Cancer
6.5.1.5.1 Prostate cancer market estimates and forecast, 2018 – 2030 (USD Million)
6.5.1.6 Others
6.5.1.6.1 Others cancer market estimates and forecast, 2018 – 2030 (USD Million)
6.5.2 Non-oncology
6.5.2.1 Non-oncology market estimates and forecast, 2018 – 2030 (USD Million)
6.5.2.2 Neurological Disorders
6.5.2.2.1 Neurological disorders market estimates and forecast, 2018 – 2030 (USD Million)
6.5.2.3 Arthitis
6.5.2.3.1 Arthritis market estimates and forecast, 2018 – 2030 (USD Million)
6.5.2.4 Others
6.5.2.4.1 Others market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 7 Radiotheranostics Market Segment Analysis, By Region, 2018 – 2030 (USD Million)
7.1 Definition & Scope
7.2 Regional Market Share Analysis, 2022 & 2030
7.3 Regional Market Dashboard
7.4 Regional Market Snapshot
7.5 SWOT Analysis
7.5.1 North America
7.5.2 Europe
7.5.3 Asia Pacific
7.5.4 Latin America
7.5.5 Middle East & Africa
7.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
7.6.1 North America
7.6.1.1 North America radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.1.2 U.S.
7.6.1.2.1 Key Country Dynamics
7.6.1.2.2 Competitive Scenario
7.6.1.2.3 Regulatory Framework
7.6.1.2.4 Reimbursement Scenario
7.6.1.2.5 U.S. radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.1.3 Canada
7.6.1.3.1 Key Country Dynamics
7.6.1.3.2 Competitive Scenario
7.6.1.3.3 Regulatory Framework
7.6.1.3.4 Reimbursement Scenario
7.6.1.3.5 Canada radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.2 Europe
7.6.2.1 Europe radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.2.2 UK
7.6.2.2.1 Key Country Dynamics
7.6.2.2.2 Competitive Scenario
7.6.2.2.3 Regulatory Framework
7.6.2.2.4 Reimbursement Scenario
7.6.2.2.5 UK radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.2.3 Germany
7.6.2.3.1 Key Country Dynamics
7.6.2.3.2 Competitive Scenario
7.6.2.3.3 Regulatory Framework
7.6.2.23.4 Reimbursement Scenario
7.6.2.3.5 Germany radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.2.4 Spain
7.6.2.4.1 Key Country Dynamics
7.6.2.4.2 Competitive Scenario
7.6.2.4.3 Regulatory Framework
7.6.2.4.4 Reimbursement Scenario
7.6.2.4.5 Spain radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.2.5 France
7.6.2.5.1 Key Country Dynamics
7.6.2.5.2 Competitive Scenario
7.6.2.5.3 Regulatory Framework
7.6.2.5.4 Reimbursement Scenario
7.6.2.5.5 France radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.2.6 Italy
7.6.2.6.1 Key Country Dynamics
7.6.2.6.2 Competitive Scenario
7.6.2.6.3 Regulatory Framework
7.6.2.6.4 Reimbursement Scenario
7.6.2.6.5 Italy radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.2.7 Denmark
7.6.2.7.1 Key Country Dynamics
7.6.2.7.2 Competitive Scenario
7.6.2.7.3 Regulatory Framework
7.6.2.7.4 Reimbursement Scenario
7.6.2.7.5 Denmark radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.2.8 Sweden
7.6.2.8.1 Key Country Dynamics
7.6.2.8.2 Competitive Scenario
7.6.2.8.3 Regulatory Framework
7.6.2.8.4 Reimbursement Scenario
7.6.2.8.5 Sweden radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.2.9 Norway
7.6.2.9.1 Key Country Dynamics
7.6.2.9.2 Competitive Scenario
7.6.2.9.3 Regulatory Framework
7.6.2.9.4 Reimbursement Scenario
7.6.2.9.5 Norway radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.3 Asia Pacific
7.6.3.1 Asia Pacific radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.3.2 Japan
7.6.3.2.1 Key Country Dynamics
7.6.3.2.2 Competitive Scenario
7.6.3.2.3 Regulatory Framework
7.6.3.2.4 Reimbursement Scenario
7.6.3.2.5 Japan radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.3.3 China
7.6.3.3.1 Key Country Dynamics
7.6.3.3.2 Competitive Scenario
7.6.3.3.3 Regulatory Framework
7.6.3.3.4 Reimbursement Scenario
7.6.3.3.5 China radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.3.4 India
7.6.3.4.1 Key Country Dynamics
7.6.3.4.2 Competitive Scenario
7.6.3.4.3 Regulatory Framework
7.6.3.4.4 Reimbursement Scenario
7.6.3.4.5 India radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.3.5 South Korea
7.6.3.5.1 Key Country Dynamics
7.6.3.5.2 Competitive Scenario
7.6.3.5.3 Regulatory Framework
7.6.3.5.4 Reimbursement Scenario
7.6.3.5.5 South Korea radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.3.6 Australia
7.6.3.6.1 Key Country Dynamics
7.6.3.6.2 Competitive Scenario
7.6.3.6.3 Regulatory Framework
7.6.3.6.4 Reimbursement Scenario
7.6.3.6.5 Australia radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.3.7 Thailand
7.6.3.7.1 Key Country Dynamics
7.6.3.7.2 Competitive Scenario
7.6.3.7.3 Regulatory Framework
7.6.3.7.4 Reimbursement Scenario
7.6.3.7.5 Thailand radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.4 Latin America
7.6.4.1 Latin America radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.4.2 Brazil
7.6.4.2.1 Key Country Dynamics
7.6.4.2.2 Competitive Scenario
7.6.4.2.3 Regulatory Framework
7.6.4.2.4 Reimbursement Scenario
7.6.4.2.5 Brazil radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.4.3 Mexico
7.6.4.3.1 Key Country Dynamics
7.6.4.3.2 Competitive Scenario
7.6.4.3.3 Regulatory Framework
7.6.4.3.4 Reimbursement Scenario
7.6.4.3.5 Mexico radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.4.4 Argentina
7.6.4.4.1 Key Country Dynamics
7.6.4.4.2 Competitive Scenario
7.6.4.4.3 Regulatory Framework
7.6.4.4.4 Reimbursement Scenario
7.6.4.4.5 Argentina radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.5 MEA
7.6.5.1 MEA radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.5.2 South Africa
7.6.5.2.1 Key Country Dynamics
7.6.5.2.2 Competitive Scenario
7.6.5.2.3 Regulatory Framework
7.6.5.2.4 Reimbursement Scenario
7.6.5.2.5 South Africa radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.5.3 Saudi Arabia
7.6.5.3.1 Key Country Dynamics
7.6.5.3.2 Competitive Scenario
7.6.5.3.3 Regulatory Framework
7.6.5.3.4 Reimbursement Scenario
7.6.5.3.5 Saudi Arabia radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.5.4 UAE
7.6.5.4.1 Key Country Dynamics
7.6.5.4.2 Competitive Scenario
7.6.5.4.3 Regulatory Framework
7.6.5.4.4 Reimbursement Scenario
7.6.5.4.5 UAE radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
7.6.5.5 Kuwait
7.6.5.5.1 Key Country Dynamics
7.6.5.5.2 Competitive Scenario
7.6.5.5.3 Regulatory Framework
7.6.5.5.4 Reimbursement Scenario
7.6.5.5.5 Kuwait radiotheranostics market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 8 Radiotheranostics Market – Competitive Analysis
8.1 Recent Developments & Impact Analysis, by Key Market Participants
8.1.1 Ansoff matrix
8.1.2 Heat map analysis
8.1.3 Major Deals and Strategic Alliances Analysis
8.1.3.1 Joint Ventures
8.1.3.2 Licensing Agreements
8.1.3.3 Product Launches
8.1.3.4 Conferences and Campaigns
8.2 Company Categorization
8.2.1 Innovators
8.2.2 Market Leaders
8.3 Vendor Landscape
8.3.1 List of key distributors and channel partners
8.3.2 Key customers
8.4 Public Companies
8.4.1 Competitive Dashboard Analysis
8.4.1.1 Market Differentiators
8.5 Private Companies
8.5.1 List of key emerging companies
8.6 Company Profiles
8.6.1 Novartis AG
8.6.1.1 Company overview
8.6.1.2 Financial performance
8.6.1.3 Product benchmarking
8.6.1.4 Strategic Initiatives
8.6.2 Progenics Pharmaceuticals, Inc. (Lantheus)
8.6.2.1 Company overview
8.6.2.2 Financial performance
8.6.2.3 Product benchmarking
8.6.2.4 Strategic Initiatives
8.6.3 Telix Pharmaceuticals Limited
8.6.3.1 Company overview
8.6.3.2 Financial performance
8.6.3.3 Product benchmarking
8.6.3.4 Strategic Initiatives
8.6.4 ITM Radiopharma
8.6.4.1 Company overview
8.6.4.2 Financial performance
8.6.4.3 Product benchmarking
8.6.4.4 Strategic Initiatives
8.6.5 Life Molecular Imaging
8.6.5.1 Company overview
8.6.5.2 Financial performance
8.6.5.3 Product benchmarking
8.6.5.4 Strategic Initiatives
8.6.6 RadioMedix
8.6.6.1 Company overview
8.6.6.2 Financial performance
8.6.6.3 Product benchmarking
8.6.6.4 Strategic Initiatives
8.6.7 IsoTherapeutics Group, LLC
8.6.7.1 Company overview
8.6.7.2 Financial performance
8.6.7.3 Product benchmarking
8.6.7.4 Strategic initiatives
8.6.8 Q BioMed Inc
8.6.8.1 Company overview
8.6.8.2 Financial performance
8.6.8.3 Product benchmarking
8.6.8.4 Strategic initiatives
8.6.9 Nordic Nanovector ASA
8.6.9.1 Company overview
8.6.9.2 Financial performance
8.6.9.3 Product benchmarking
8.6.9.4 Strategic initiatives
Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Leading Market Players Anticipated to Witness Highest Growth
Table 4 Global Radiotheranostics Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 6 Global Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 7 Global Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 8 North America Radiotheranostics Market, By Country, 2018 - 2030 (USD Million)
Table 9 North America Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 10 North America Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 11 North America Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 12 U.S. Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 13 U.S. Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 14 U.S. Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 15 Canada Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 16 Canada Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 17 Canada Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 18 Europe Radiotheranostics Market, By Country, 2018 - 2030 (USD Million)
Table 19 Europe Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 20 Europe Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 21 Europe Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 22 UK Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 23 UK Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 24 UK Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 25 Germany Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 26 Germany Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 27 Germany Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 28 France Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 29 France Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 30 France Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 31 Italy Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 32 Italy Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 33 Italy Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 34 Spain Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 35 Spain Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 36 Spain Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 37 Denmark Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 38 Denmark Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 39 Denmark Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 40 Norway Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 41 Norway Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 42 Norway Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 43 Sweden Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 44 Sweden Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 45 Sweden Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 46 Asia Pacific Radiotheranostics Market, By Country, 2018 - 2030 (USD Million)
Table 47 Asia Pacific Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 48 Asia Pacific Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 49 Asia Pacific Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 50 Japan Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 51 Japan Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 52 Japan Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 53 China Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 54 China Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 55 China Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 56 India Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 57 India Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 58 India Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 59 South Korea Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 60 South Korea Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 61 South Korea Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 62 Australia Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 63 Australia Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 64 Australia Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 65 Thailand Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 66 Thailand Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 67 Thailand Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 68 Latin America Radiotheranostics Market, By Country, 2018 - 2030 (USD Million)
Table 69 Latin America Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 70 Latin America Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 71 Latin America Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 72 Brazil Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 73 Brazil Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 74 Brazil Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 75 Argentina Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 76 Argentina Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 77 Argentina Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 78 Mexico Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 79 Mexico Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 80 Mexico Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 81 Middle East and Africa Radiotheranostics Market, By Country, 2018 - 2030 (USD Million)
Table 82 Middle East and Africa Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 83 Middle East and Africa Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 84 Middle East and Africa Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 85 Saudi Arabia Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 86 Saudi Arabia Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 87 Saudi Arabia Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 88 UAE Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 89 UAE Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 90 UAE Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
Table 91 Kuwait Radiotheranostics Market, By Radioisotope, 2018 - 2030 (USD Million)
Table 92 Kuwait Radiotheranostics Market, By Approach, 2018 - 2030 (USD Million)
Table 93 Kuwait Radiotheranostics Market, By Application, 2018 - 2030 (USD Million)
